Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 6/20 | 0.48 |
| ▸ | ADORA2B | P29275 | 4/20 | 0.48 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.46 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | NT5E | P21589 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31228269 | 0.85 | NT5E (0.62) | ADORA2AADORA2BADORA3ADORA1LMNA | |
| SCHEMBL31228219 | 0.84 | ADORA3 (0.61) | ADORA2AADORA2BADORA3ADORA1LMNA | |
| SCHEMBL13844404 | 0.80 | PRMT5 (0.61) | ADORA2AADORA2BADORA3ADORA1 | |
| SCHEMBL14947688 | 0.78 | ADORA3 (0.71) | ADORA2AADORA2BADORA3ADORA1LMNA | |
| SCHEMBL22616893 | 0.78 | ADORA3 (0.71) | ADORA2AADORA2BADORA3ADORA1LMNA | |
| SCHEMBL14401012 | 0.78 | ADORA3 (0.71) | ADORA2AADORA2BADORA3ADORA1LMNA | |
| SCHEMBL14145063 | 0.78 | ADORA3 (0.71) | ADORA2AADORA2BADORA3ADORA1LMNA | |
| SCHEMBL31725323 | 0.78 | AHCY (0.49) | ADORA2AADORA2BADORA3ADORA1LMNA | |
| SCHEMBL31725350 | 0.77 | NT5E (0.60) | ADORA2AADORA2BADORA3ADORA1LMNA | |
| SCHEMBL18490509 | 0.76 | ADORA3 (0.57) | ADORA3NT5E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4705313-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | The Scripps Research Institute (US) | 2026-03-11 | — | — | EP | claimed |
| WO-2024227159-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2024-10-31 | — | — | WO | claimed |
| EP-4705313-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | The Scripps Research Institute (US) | 2026-03-11 | — | — | EP | disclosed |
| WO-2024227159-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2024-10-31 | — | — | WO | disclosed |
| CN-115667279-A | Synthesis of 3' N nucleoside through oxime intermediate and related compounds | 詹森生物制药有限公司 | 2023-01-31 | — | — | CN | disclosed |